Expression of the myeloperoxidase gene in AC133 positive leukemia cells relates to the prognosis of acute myeloid leukemia

Leukemia Research

Volumn 30, Issue 9, 2006, Pages 1105-1112

  Taguchi, Jun ^a   Miyazaki, Yasushi ^a   Tsutsumi, Chizuko ^a   Sawayama, Yasushi ^a   Ando, Koji ^a   Tsushima, Hideki ^a   Fukushima, Takuya ^a   Hata, Tomoko ^a   Yoshida, Shinichiro ^b   Kuriyama, Kazutaka ^c   Honda, Sumihisa ^d   Jinnai, Itsuro ^a   Mano, Hiroyuki ^e   Tomonaga, Masao ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

AC133; Acute myeloid leukemia; Gene expression; Myeloperoxidase; Prognostic factor

Indexed keywords

CD133 ANTIGEN; MYELOPEROXIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CELL COMPARTMENTALIZATION; CHROMOSOME TRANSLOCATION 21; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROGNOSIS; STEM CELL; SURVIVAL;

ANTIGENS, CD; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, LEUKEMIC; GLYCOPROTEINS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; NEOPLASM PROTEINS; PEPTIDES; PEROXIDASE; PROGNOSIS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 33745863118     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.12.012     Document Type: Article

References (34)

1. Babior B.M. Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med 298 (1978) 659-668
2. Babior B.M. Oxygen-dependent microbial killing by phagocytes (second of two parts). N Engl J Med 298 (1978) 721-725
3. Koeffler H.P., Ranyard J., and Pertcheck M. Myeloperoxidase: its structure and expression during myeloid differentiation. Blood 65 (1985) 484-491
4. Winterbourn C.C., Vissers M.C., and Kettle A.J. Myeloperoxidase. Curr Opin Hematol 7 (2000) 53-58
5. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. Proposed revised criteria for the classification of acute myeloid leukaemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103 (1985) 620-629
6. Hoyle C.F., Gray R.G., Wheatley K., Swirsky D., de Bastos M., Sherrington P., et al. Prognostic importance of Sudan Black positivity: a study of bone marrow slides from 1386 patients with de novo acute myeloid leukaemia. Br J Haematol 79 (1991) 398-407
7. Matsuo T., Cox C., and Bennett J.M. Prognostic significance of myeloperoxidase positivity of blast cells in acute myeloblastic leukemia without maturation (FAB: M1): an ECOG study. Hematol Pathol 3 (1989) 153-158
8. Matsuo T., Kuriyama K., Miyazaki Y., Yoshida S., Tomonaga M., Emi N., et al. The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype. Leukemia 17 (2003) 1538-1543
9. Yin A.H., Miraglia S., Zanjani E.D., Almeida-Porada G., Ogawa M., Leary A.G., et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90 (1997) 5002-5012
10. Miraglia S., Godfrey W., Yin A.H., Atkins K., Warnke R., Holden J.T., et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90 (1997) 5013-5021
11. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3 (1997) 730-737
12. de Wynter E.A., Buck D., Hart C., Heywood R., Coutinho L.H., Clayton A., et al. CD34+ AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 16 (1998) 387-396
13. Bhatia M., Bonnet D., Murdoch B., Gan O.I., and Dick J.E. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 4 (1998) 1038-1045
14. Gallacher L., Murdoch B., Wu D.M., Karanu F.N., Keeney M., and Bhatia M. Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 95 (2000) 2813-2820
15. Shmelkov S.V., Jun L., St Clair R., McGarrigie D., Derderian C.A., Usenko J.K., et al. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood 103 (2004) 2055-2061
16. Ohmine K., Ota J., Ueda M., Ueno S., Yoshida K., Yamashita Y., et al. Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells. Oncogene 20 (2001) 8249-8257
17. Qian Z., Fernald A.A., Godley L.A., Larson R.A., and Le Beau M.M. Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukaemia. Proc Natl Acad Sci USA 99 (2002) 14925-14930
18. Tsutsumi C., Ueda M., Miyazaki Y., Yamashita Y., Choi Y.L., Ota J., et al. DNA microarray analysis of dysplastic morphology associated with acute myeloid leukemia. Exp Hematol 32 (2004) 828-835
19. Kuriyama K., Tomonaga M., Matsuo T., Kobayashi T., Miwa H., Shirakawa S., et al., Japan Adult Leukaemia Study Group (JALSG). Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. Br J Haematol 86 (1994) 767-773
20. Gabert J., Beillard E., van der Velden V.H.J., Bi W., Grimwade D., Pallisgaard N., et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukaemia-A Europe Against Cancer Program. Luekemia 17 (2003) 2318-2357
21. Shibata A., Bennett J.M., Castoldi G.L., Catovsky D., Flandrin G., Jaffe E.S., et al. Recommended methods for cytological procedures in haematology. International Committee for Standardization in Haematology (ICSH). Clin Lab Haematol 7 (1985) 55-74
22. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92 (1998) 2322-2333
23. Miyazaki Y., Kuriyama K., Miyawaki S., Ohtake S., Sakamaki H., Matsuo T., et al. Cytogenetic heterogeneity of acute myeloid leukaemia (AML) with trilineage dysplasia: Japan Adult Leukaemia Study Group-AML 92 study. Br J Haematol 120 (2003) 56-62
24. Vercauteren S.M., and Sutherland H.J. CD133 (AC133) expression on AML cells and progenitors. Cytotherapy 3 (2001) 449-459
25. Fauth F., Weidmann E., Martin H., Schneider B., Sonnhoff S., and Hoelzer D. AC133 expression on acute myeloid leukemia blasts: correlation to FAB and to CD34 expression and possible implications for peripheral blood progenitor cell purging in AML. Leuk Res 25 (2001) 191-196
26. Kuci S., Wessels J.T., Buhring H.J., Schilbach K., Schumm M., Seitz G., et al. Identification of a novel class of human adherent CD34-stem cells that give rise to SCID-repopulating cells. Blood 101 (2003) 869-876
27. Koehl U., Zimmermann S., Esser R., Sorensen J., Gruttner H.P., Duchscherer M., et al. Autologous transplantation of CD133 selected hematopoietic progenitor cells in a pediatric patient with relapsed leukemia. Bone Marrow Transplant 29 (2002) 927-930
28. Zaki S.R., Austin G.E., Swan D., Srinivasan A., Ragab A.H., and Chan W.C. Human myeloperoxidase gene expression in acute leukemia. Blood 74 (1989) 2096-2102
29. Chang K.S., Trujillo J.M., Cook R.G., and Stass S.A. Human myeloperoxidase gene: molecular cloning and expression in leukemic cells. Blood 68 (1986) 1411-1414
30. Austin G.E., Chan W.C., Zhao W., and Racine M. Myeloperoxidase gene expression in normal granulopoiesis and acute leukemias. Leuk Lymphoma 15 (1994) 209-220
31. Hu M., Krause D., Greaves M., Sharkis S., Dexter M., Heyworth C., et al. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev 11 (1997) 774-785
32. Akashi K., Traver D., Miyamoto T., and Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404 (2000) 193-197
33. Ye M., Iwasaki H., Laiosa C.V., Stadtfeld M., Xie H., Heck S., et al. Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential. Immunity 19 (2003) 689-699
34. Lowenberg B., Downing J.R., and Burnett A. Acute myeloid leukemia. N Engl J Med 341 (1999) 1051-1062